Sign in
Sa1615 SGLT2I REDUCES THE RISK OF DEVELOPING HCC IN PATIENTS WITH CO-EXISTING HEPATITIS C INFECTION AND TYPE 2 DIABETES: A GLOBAL MULTICENTER PROPENSITY-MATCHED STUDY
Abstract   Peer reviewed

Sa1615 SGLT2I REDUCES THE RISK OF DEVELOPING HCC IN PATIENTS WITH CO-EXISTING HEPATITIS C INFECTION AND TYPE 2 DIABETES: A GLOBAL MULTICENTER PROPENSITY-MATCHED STUDY

Abdullah Sohail, Aysha Aslam, Ammad J. Chaudhary, Muhammad M. Bhinder and Kyle Brown
Gastroenterology (New York, N.Y. 1943), Vol.166(5 Supplement), pp.S-1598-S-1599
05/18/2024
DOI: 10.1016/S0016-5085(24)04131-3

View Online

Details

Metrics

2 Record Views